博士后
当前位置:首页 > 科研团队 > 博士后
钟伊南

钟伊南,博士。2015年苏州大学获博士学位,2014年1-3月在德国柏林自由大学交流学习,2015-2017年苏州大学博士后。现获得中国博士后科学基金面上资助和江苏省博士后科研资助。主要研究方向为刺激响应性聚合物纳米药物用于高效靶向肿瘤治疗。

代表性著作 

1. Y.N. Zhong, M. Dimde, D. Stöbener, F.H. Meng*, C. Deng, Z.Y. Zhong*, R. Haag, Micelles with Sheddable Dendritic Polyglycerol Sulfate Shells Show Extraordinary Tumor Targetability and Chemotherapy In Vivo, ACS Applied Materials & Interfaces, 2016, 8 (41), 27530–27538.

2. Y.N. Zhong, K. Goltsche, L. Cheng, F. Xie, F.H. Meng**, C. Deng, Z.Y. Zhong*, R. Haag, Hyaluronic Acid-Shelled Acid-Activatable Paclitaxel Prodrug Micelles Effectively Target and Treat CD44-Overexpressing Human Breast Tumor Xenografts In Vivo, Biomaterials, 2016, 84, 250-261.

3. Y.N. Zhong, J. Zhang, R. Cheng, C. Deng, F.H. Meng, F. Xie, Z.Y. Zhong*. Disulfide-Crosslinked Hyaluronic Acid Nanoparticles for CD44-Targeting and Active Intracellular Drug Delivery. Nanomedicine 2016, 12, 498-499.

4. Y.N. Zhong, J. Zhang, R. Cheng*, C. Deng, F.H. Meng, F. Xie*, Z.Y. Zhong*, Reversibly Crosslinked Hyaluronic Acid Nanoparticles for Active Targeting and Intelligent Delivery of Doxorubicin to Drug Resistant CD44+ Human Breast Tumor Xenografts, Journal of Controlled Release, 2015, 205, 144–154.

5. Y.N. Zhong, C. Wang, F.H. Meng*, Z. Liu, Z.Y. Zhong*. cRGD-Functionalized AuNR-Cored PEG-PCL Nanoparticles for Efficacious Glioma Chemotherapy. Journal of Controlled Release 2015, 213, e135.

6. Y.N. Zhong, C. Wang, R. Cheng, L. Cheng, F.H. Meng*, Z. Liu*, Z.Y. Zhong*, cRGD-Directed, NIR-Responsive and Robust AuNR/PEG–PCL Hybrid Nanoparticles for Targeted Chemotherapy of Glioblastoma In Vivo, Journal of Controlled Release, 2014, 195, 63–71.

7. Y.N. Zhong, F.H. Meng, C. Deng*, and Z.Y. Zhong*, Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy, Biomacromolecules, 2014, 15, 1955−1969.

8. F.H. Meng, Y.N. Zhong, R. Cheng, C. Deng, and Z.Y. Zhong*, pH-Sensitive Polymeric Nanoparticles for Tumor-Targeting Doxorubicin Delivery: Concept and Recent Advances, Nanomedicine, 2014, 9(3), 487–499.

9. Y.N. Zhong, W.J. Yang, H.L. Sun, R. Cheng, F.H. Meng, C. Deng,* and Z.Y. Zhong*, Ligand-Directed Reduction-Sensitive Shell-Sheddable Biodegradable Micelles Actively Deliver Doxorubicin into the Nuclei of Target Cancer Cells, Biomacromolecules, 2013, 14, 3723–3730.

10. Y.N. Zhong, C. Wang, L. Cheng, F.H. Meng, Z.Y. Zhong*, and Z. Liu*, Gold Nanorod-Cored Biodegradable Micelles as a Robust and Remotely Controllable Doxorubicin Release System for Potent Inhibition of Drug-Sensitive and -Resistant Cancer Cells, Biomacromolecules, 2013, 14, 2411-2419.

11. Y.D. Gu, Y.N. Zhong, F.H. Meng*, R. Cheng, C. Deng, and Z.Y. Zhong*, Acetal-Linked Paclitaxel Prodrug Micellar Nanoparticles as a Versatile and Potent Platform for Cancer Therapy, Biomacromolecules, 2013, 14, 2772–2780.

12. Y.N. Zhong, C. Wang, X.J. Wang, L. Cheng, F.H. Meng, Z.Y. Zhong, Z. Liu. Gold Nanorod-Cored Micelles as A Remotely-Controllable Near IR-Triggered Drug Release System for Effective Killing of Drug Resistant Cancer Cells. Journal of Controlled Release 2013, 172, e86-e87.

13. S.K. Li, F.H. Meng, Z.J. Wang, Y.N. Zhong, M. Zheng, H.Y. Liu, Z.Y. Zhong*, Biodegradable Polymersomes with an Ionizable Membrane: Facile Preparation, Superior Protein Loading, and Endosomal pH-Responsive Protein Release, European Journal of Pharmaceutics and Biopharmaceutics, 2012, 82, 103-111.

14. M. Zheng, Y.N. Zhong, F.H. Meng, R. Peng, and Z.Y. Zhong*, Lipoic Acid Modified Low Molecular Weight Polyethylenimine Mediates Nontoxic and Highly Potent In Vitro Gene Transfection, Molecular Pharmaceutics, 2011, 8, 2434-2443.

返回